Request to Join
has invited you to join this group
Namita Seth Mohta, MD, is a physician executive with expertise in health care delivery transformation. As the Executive Editor for NEJM Catalyst, a new journal focused on practical innovations in healthcare delivery, she is part of the founding leadership team who built and launched the platform and has responsibility for on-going editorial content strategy and quality. Dr. Mohta is also faculty at Ariadne Labs, a health system innovation lab at Brigham & Women’s Hospital and the T.H. Chan School of Public Health, where she is part of the Serious Illness Care Program (SICP). Dr Mohta leads scale and spread of initiatives that improve outcomes for patients with serious illness.
Dr Mohta has been part of the founding Population Health and ACO leadership teams at both Partners Health Care and the New England Quality Care Alliance (Tufts Medical Center), both in Boston. As Medical Director, her responsibilities have included the design, implementation, and scale of value-based strategies for Medicare, Medicaid, and Commercial populations, with a focus on primary and specialty care redesign, complex care management, analytics and measurement, and leading change management efforts. Dr. Mohta has industry experience as a management consultant with the Boston Consulting Group. She often consults with health-care technology start-ups (currently with PatientPing and Day Health Strategies) to provide strategic and technical expertise that result in impactful products and services. Dr. Mohta practices internal medicine as a hospitalist at the Brigham and Women’s Hospital. She is faculty at the Center for Healthcare Delivery Sciences and at Harvard Medical School. She completed her Internal Medicine and Primary Care residency training at Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.
Peter Lachman M.D. MPH. M.B.B.Ch., FRCPCH, FCP (SA), FRCPI assumed the position of ISQua Chief Executive Officer on 1st May 2016. He has great experience as a clinician and leader in quality improvement and patient safety.
Dr Lachman was a Health Foundation Quality Improvement Fellow at IHI in 2005-2006, and developed the quality improvement programme at Great Ormond Street Hospital where he was the Deputy Medical Director with the lead for Patient Safety. Prior to joining ISQua, Peter was also a Consultant Paediatrician at the Royal Free Hospital in London specialising in the challenge of long term conditions for children.
Dr Lachman has been the National Clinical Lead for SAFE, a Heath Foundation funded RCPCH programme which aims to improve situation awareness in clinical teams. In Ireland he is Lead International Faculty at the RCPI in Dublin, where he co-directs the Leadership and Quality programme to develop clinical leaders in quality improvement. He is co-founder and Chairperson of PIPSQC, the Paediatric International Patient Safety and Quality Community.
Maureen Bisognano, President Emerita and Senior Fellow, at the Institute for Healthcare Improvement (IHI), previously served as IHI’s President for 5 years and Executive Vice President and COO for 15 years. She is a prominent authority on improving health care systems, whose expertise has been recognized by her elected membership to the National Academy of Medicine, among other distinctions.
Ms. Bisognano advises health care leaders around the world, is a frequent speaker at major health care conferences on quality improvement, and is a tireless advocate for change. She is also an Instructor of Medicine at Harvard Medical School, a Research Associate in the Brigham and Women's Hospital Division of Social Medicine and Health Inequalities, and serves on the boards of the Commonwealth Fund, Indiana University Health System, and Nursing Now, global campaign to strengthen nursing in every country.
Ms. Bisognano chairs the advisory board for the Well Being Trust, an independent institute with the mission to improve mental health and resilience across all ages in the US. She co-chairs, with Dr. Atul Gawande, the Massachusetts Coalition on Serious Illness Care. She serves as the chair for membership for the National Academy of Medicine section on administration. Prior to joining IHI, Ms. Bisognano was Senior Vice President of the Juran Institute, where she consulted with senior management on the implementation of total quality management in health care settings. Before that, she served as Chief Executive Officer of the Massachusetts Respiratory Hospital in Braintree, MA, where she implemented a hospital-wide strategic plan that improved the quality of care while simultaneously reducing costs. eventually serving as Chief Operating Officer from 1984-1987.
Dr. Clifford Ko is the Director of the Division of Research and Optimal Patient Care at the American College of Surgeons, where he oversees the College’s quality improvement programs. Dr. Ko’s work primarily focuses on surgical quality of care, including quality measurement, process improvement, value-based care, and achieving high reliability in surgical care. Clinically, Dr. Ko is a double board-certified surgeon with a practice currently focusing on patients with colorectal cancer. At UCLA, he is the Robert and Kelly Day Professor of Surgery. He is also Professor of Health Services at the UCLA School of Public Health.
Dr. Ko received his B.A (Biology), M.S. (Biological/Medical Ethics), and M.D. from the University of Chicago. He also received a Masters of Science Degree (Health Services/Outcomes Research) from the University of California, Los Angeles during his time as a Robert Wood Johnson Clinical Scholars Fellow at UCLA and RAND. Dr. Ko completed his General Surgery Residency at UCLA Medical Center, and obtained specialty training at the Lahey Clinic in Boston in Colon and Rectal Surgery.
Dr. Turchin is Director of Quality in Diabetes at the Division of Endocrinology at Brigham and Women's Hospital and Associate Professor of Medicine at Harvard Medical School. Dr. Turchin is a graduate of Johns Hopkins University School of Medicine and Massachusetts Institute of Technology (Medical Informatics). He studies quality and outcomes of care of patients with chronic cardiometabolic conditions, including diabetes, hyperlipidemia and hypertension using advanced electronic medical record data analytics.
Dr. Turchin is a Fellow of the American College of Medical Informatics and has published over 90 papers and book chapters; his research has been funded by AHRQ, NIH, PCORI and private foundations. Dr. Turchin serves on the Endocrine Society Quality Improvement Subcommittee and is the founding Chair of the Healthcare Delivery and Quality Improvement Interest Group at the American Diabetes Association.
Lisa B. Caruso, MD, MPH is an Assistant Professor of Medicine in the Section of Geriatrics at Boston University School of Medicine. She has strong interests in dementia and diabetes in the older adult. She is the recipient of a Geriatric Academic Career Award in 2002 which allowed her to study the underserved, frail older population with diabetes and cardiovascular disease using evidence-based skills. She is currently the Director of Quality and Patient Safety for the Department of Medicine. She mentors fourth year medical students and internal medicine residents in quality improvement projects relevant to patient care at Boston Medical Center. Her clinical work is in the Geriatrics Ambulatory Practice, the Geriatrics Inpatient Service, and in sub-acute and long-term care.
Lucy is a Pediatric Registrar at London Northwest Healthcare NHS Trust, and Faculty at the Institute for Healthcare Improvement (IHI), Cambridge MA. Lucy is passionate about the upstream determinants of child and adolescent health, improvement science, and the coproduction of healthcare. She is a hospital pediatrician, has an MPH from Harvard, and a medical degree and BSc from Imperial College.
Dr. Cerasale received his undergraduate degree in biology from Purdue University, and then attained his medical degree from the Indiana University School of Medicine, and later his master of public health degree from Michigan State University. He completed his Internal Medicine residency at Henry Ford Hospital in Detroit, MI, where he was selected as a chief medical resident and remained as an attending in the Division of Hospital Medicine. Dr. Cerasale served as the Performance Improvement Director for Hospital Medicine and was the QI Teaching and Research Director for Inpatient Services within the Internal Medicine residency program. In those roles, he launched a quality improvement and patient safety focused curriculum on the Hospital Medicine teaching service. He also initiated the implementation of an EHR-based venous thromboembolism risk stratification tool across the health system. Currently, Dr. Cerasale is an Assistant Professor of Medicine at the University of Chicago Medicine and is the Director of Quality Improvement for the Section of Hospital Medicine. At the University of Chicago, Dr. Cerasale helps deliver the QI curriculum for Internal Medicine, as well as lectures on QI topics to undergraduates, medical students, and faculty. His major improvement projects include EHR optimization for provider use and data collection, development of actionable provider-level clinical metrics, and continued implementation of evidence-based venous thromboembolism practices via EHR-supported tools. Dr. Cerasale is actively engaged with the Society of Hospital Medicine, from which he has received the designation of Senior Fellow and is the current chair of the Quality Improvement Special Interest Group. His quality improvement work has been recognized by the National Quality Foundation, Institute for Healthcare Improvement, Society of Hospital Medicine, American Heart Association, and American College of Physicians.
Emily Fondahn MD is an Internal Medicine physician and Associate Program Director at Washington University in St Louis. Her current work includes reducing hospital readmissions for patients, improving outcomes of patients with diabetes, and enhancing communication between physicians. She oversees the Patient Safety and Quality Improvement education for the medical students and is passionate about PSQI education across the healthcare continuum. Dr. Fondahn is an editor of the Washington University Manual for Patient Safety & Quality Improvement.
Dr. Philip Lam is an Infectious Diseases physician at Sunnybrook Health Sciences Centre and Assistant Professor at the University of Toronto. He obtained a Bachelor of Science degree in Pharmacy at the University of Toronto, followed by a degree in Medicine at Queen's University. He returned to Toronto to complete a residency and Internal Medicine and fellowship in Infectious Diseases. During fellowship, he was the resident-lead in a quality improvement project aimed at reducing the inappropriate use of double-lumen peripherally inserted central catheters. He recently completed a Master's degree in Quality Improvement at University of Toronto, with his thesis focused on improving cefazolin use as pre-operative prophylaxis in patients with a reported beta-lactam allergy. His other interests include antimicrobial stewardship, and improving the use of virtual care in the management of infectious diseases.
Brant Oliver is a healthcare improvement and implementation scientist, educator, and board-certified family and psychiatric nurse practitioner (FNP-BC, PMHNP-BC). Dr. Oliver's work focuses on applied healthcare improvement science research with a focus on "3C" (complex, costly, and chronic) conditions including MS, IBD, CF, RA and others, coproduction, learning health systems, and shared decision making (SDM). He has been in clinical practice since 2003, working primarily as a certified MS specialist (MSCN) and a MS neurobehavioral nurse practitioner.
Dr. Oliver holds faculty appointments at Dartmouth, VA Quality Scholars (VAQS), and the MGH Institute of Health Professions School of Nursing. He is a Lean Six Sigma Black Belt and experienced in Clinical Microsystems and IHI Model for Improvement approaches, including IHI Breakthrough Series (BTS) collaboratives. He teaches graduate students, residents and post-doctoral fellows in improvement science, methodology, measurement, and analytics.
Dr. Oliver is principal investigator of the first multi-center improvement science research collaborative for multiple sclerosis (MS-CQI), and the new Next Generation Learning Health System for Multiple Sclerosis multi-center research collaborative (Next-Gen MS), and is or has been an investigator, methodologist, and/or faculty in large scale improvement efforts in the US, UK, Sweden, Canada, and Australia, including the Cystic Fibrosis Foundation, the Crohn's & Colitis Foundation, and the International Coproduction of Health Network (ICoHN). He is also PI of CO-VALUE, an ICoHN study developing an assessment model for coproduction value creation in an international community of practice that he co-leads with visionary improvement scholar Dr. Paul Batalden and includes participation of health systems in the United States, United Kingdom, Israel, and Sweden.
I am a hospital medicine physician interested in quality improvement, patient safety, and medical education. My current QI and research projects include work on hospital complications, ORYX measures, medication reconciliation, and transitions of care. I oversee QI education and projects for the Internal Medicine Residency Program at Duke as the Associate Program Director for Quality Improvement and Patient Safety and help co-lead our Residency Patient Safety and Quality Council.
Greg Ogrinc is the Senior Vice President, Certification Standards and Programs at the American Board of Medical Specialties (ABMS). He provides strategic leadership for the ongoing evolution and implementation of ABMS board certification standards and programming. Before joining the ABMS in 2020, he was the Senior Associate Dean for Medical Education at the Geisel School of Medicine at Dartmouth and Professor of Medicine and of the Dartmouth Institute. Dr. Ogrinc graduated from Case Western Reserve University School of Medicine, residency in internal medicine at MetroHealth Medical Center, and the VA National Quality Scholars Program at WRJ VA. Dr. Ogrinc is the lead author of the Fundamentals of Healthcare Improvement textbook and co-leader of the Standards for Quality Improvement Reporting Excellence (SQUIRE) guidelines, a set of publication guidelines for sharing quality improvement work through published literature.
Dr. Naseema Merchant is currently a member in the section of Academic Hospital Medicine and Pulmonary Medicine at the VA Connecticut Health Care System and an Assistant Professor in the section of General Internal Medicine at Yale School of Medicine. She is the site-director of the internal Medicine Clerkship and program director for the Chief Residency Program in Quality Improvement and Patient Safety at the VA Connecticut. She also serves in the role of co-director for the Distinction Pathway in Quality Improvement and Physician Leadership for the Yale Internal Medicine Residents.
Dr. Sonali Desai is an Assistant Professor of Medicine at Harvard Medical School and a practicing rheumatologist. She serves as the Medical Director of Ambulatory Patient Safety at Brigham and Women’s Hospital, the Medical Director of Quality for the Department of Medicine, and is a practicing rheumatologist. Dr. Desai conducts research on improving the quality of care and patient safety with a focus on the ambulatory setting, with over 30 peer-reviewed publications. Dr. Desai’s contributions at Brigham & Women’s hospital (BWH) cover clinical care, research, administrative, and teaching roles. She sees complex rheumatology patients at the BWH Arthritis Center, a busy, tertiary care referral practice with both local and regional referrals and at the BWH Fish Center for Women’s Health, a multispecialty practice with a unique, integrated care model for women with rheumatic diseases.
In the Department of Medicine’s Quality Program, Dr. Desai has lead work on chronic disease management in diabetes, hypertension and rheumatoid arthritis; high-risk hospital admissions for heart failure and COPD; opioid management, subspecialty focused care such as inflammatory bowel disease, hepatitis, HIV, and asthma. In the Ambulatory Patient Safety realm, Dr. Desai has developed programs in safety reporting and feedback, medication reconciliation, S.A.F.E. approach for staff safety, and safety nets to reduce missed and delayed diagnosis of colon and lung cancer. She is expanding her team and focus to pharmacist-led medication error reduction, safety nets for cervical, breast and prostate cancer, and diagnostic error. Her work has lead to her receiving the Donabedian Award in Quality & Safety in 2019 from the American Public Health Association for Ambulatory Safety Nets and Diagnostic Error Reduction.
Dr. Desai is also and served as a Program Director (2015-2017) for an innovative global education, blended learning course titled Safety, Quality, Informatics, and Leadership at HMS. She is a native of Massachusetts and attended both college and medical school at Brown University in Rhode Island. She completed her internal medicine residency and Chief residency at Beth Israel Deaconess Medical Center in Boston, her rheumatology fellowship at BWH, and her Master’s in Public Health at the Harvard School of Public Health.
Mary Dixon-Woods is Director of THIS Institute and is The Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge.
She is a fellow of the Academy of Social Sciences and the Academy of Medical Sciences, an honorary fellow of the Royal College of Physicians and the Royal College of General Practitioners, and a Professorial Fellow at Homerton College, Cambridge. Mary is also an NIHR Senior Investigator, and Co-Editor-in-Chief of BMJ Quality and Safety.
Mary leads a programme of research focused on healthcare improvement, healthcare ethics, and methodological innovation in studying healthcare. She holds honorary positions as an adjunct professor in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University and as a visiting professor at the University of Leicester. She served on the National Advisory Group on the Safety of Patients in England, which produced the Berwick report in 2013. She also served on the review of information technology in the NHS led by Professor Bob Wachter, which reported in 2016. She was a Wellcome Trust Senior Investigator 2012-2019. Mary was the Harveian Orator for the Royal College of Physicians in 2018, the 500th anniversary of the College’s founding.
Eric Schneider, M.D., M.Sc., is senior vice president for policy and research at The Commonwealth Fund, a national philanthropy engaged in independent research on health and social policy issues. A member of The Commonwealth Fund’s executive management team, Dr. Schneider provides strategic guidance to the organization's research on topics in policy, health services delivery, and public health as well as scientific review of initiatives, grants, projects, and publications. He is a member of the board of AcademyHealth.
Trained in primary care general internal medicine and health services research, Dr. Schneider is among the nation’s leading health services researchers. His research has spanned health policy, quality measurement, quality improvement, delivery system innovation, primary care, health information technology, program evaluation, clinical sciences, and the effects of health insurance and access to care for vulnerable populations. Prior to joining the Fund, Dr. Schneider was principal researcher at the RAND Corporation and he held the RAND Distinguished Chair in Health Care Quality. In 2009, he was the first director of RAND’s Boston office, building a highly successful multidisciplinary health services research team. From 1997 to 2015 he was a professor and researcher at the Harvard School of Public Health and Harvard Medical School, teaching health policy and quality improvement in health care and practicing primary care internal medicine at the Jen Center for Primary Care at Brigham and Women’s Hospital.
Dr. Schneider holds a B.S., cum laude, in Biology from Columbia University, an M.Sc. from the University of California, Berkeley, and an M.D. from the University of California, San Francisco. He has been elected to fellowship in both the American College of Physicians and the National Academy of Social Insurance.
Dr. Nina M Dadlez is the Medical Director of Quality at Floating Hospital for Children and an Assistant Professor of Pediatrics at Tufts University School of Medicine. Dr. Dadlez is a strong proponent of patient safety, family centered care and evidence based medicine. She is interested in rigorously investigating pediatric patient safety and quality improvement. Her research focuses on reduction of medication prescribing errors, understanding the epidemiology of preventable medical errors in the pediatric population and safe transitions of care throughout the medical system. She has served as a quality improvement coach for several national quality improvement collaboratives as well as serving as a resource to faculty and trainees in the development and execution of quality improvement projects at the local level. Dr. Dadlez attended the University of Connecticut School of Medicine and completed her pediatric residency training at Morgan Stanley Children’s Hospital (Columbia University). Dr. Dadlez completed a Pediatric Hospital Medicine Fellowship at the Children’s Hospital at Montefiore and a Masters in Clinical Research Methods at Albert Einstein College of Medicine.
Hyung (Harry) Cho, MD, SFHM, FACP is Chief Value Officer at NYC Health + Hospitals system, the largest public health system in the US. His work focuses on the intersection of overuse and patient safety, and he aims to eliminate unnecessary testing and treatment that cause physical and financial harm for patients.
Since Dr. Cho became an academic hospitalist in 2011, he received over 50 awards and recognitions. He was named in three national “Under 40” lists - Top 25 Emerging Leaders by Modern Healthcare, 40 Under 40 Leaders in Health by National Minority Quality Forum, and 50 Leaders in Healthcare Under 40 from Becker’s Hospital Review. He received SHM Award of Excellence for Clinical Leadership for Physicians, AMA Excellence in Medicine Leadership Award, and Top Hospitalist honor from ACP Hospitalist magazine. His collective work in high value care at Mount Sinai was recognized with both the Quality and Practice Innovation Award from SGIM and the Award of Excellence for Teamwork in Quality Improvement from SHM. He serves as Director of QI Implementation at High Value Practice Academic Alliance. His past roles include Senior Fellow for Lown Institute, Chair of High Value Care committee for Society of Hospital Medicine, System Patient Safety Officer for NYC Health + Hospitals. He has led the development of overuse recommendations for RightCare Alliance and Society of Hospital Medicine.
Kevin J. O’Leary, MD, MS, is the John T. Clarke Professor of Medicine, Chief of the Division of Hospital Medicine and Associate Chair for Quality in the Department of Medicine at Northwestern University Feinberg School of Medicine. Kevin also serves as the Medical Director for Quality at Northwestern Memorial Hospital. In recognition of his leadership in developing one of first nationally respected academic hospital medicine groups, he received the SHM National Award for Clinical Excellence in 2008. He is the founding Director of the Northwestern Medicine Academy for Quality and Safety Improvement (NM AQSI), a professional development program to train leaders in quality improvement. In 2015, AQSI received the Leape Ahead Award from the American Association for Physician Leadership. He is the author of peer reviewed publications related to hospital medicine, medical education, healthcare quality, and patient safety. His primary research interest is interprofessional collaboration and teamwork. He currently serves as principal investigator of the Redesigning Systems to Enhance Teamwork and Quality for Hospitalized Patients (RESET) project, a study funded through the Agency for Healthcare Research and Quality (AHRQ) which provides mentored implementation to help hospitals redesign clinical microsystems to improve patient outcomes. He also serves as Deputy Editor for the Joint Commission Journal on Quality and Patient Safety.
Dr. Jencks is an independent consultant in healthcare safety and quality and Senior Fellow at the Institute for Healthcare Improvement. His work focuses on understanding and preventing hospital readmissions and other harms from poor coordination of care, and his 2009 NEJM article on hospital readmissions in Medicare is considered authoritative. At the Federal Centers for Medicare & Medicare Services (1984-2007) he was Chief Scientist in the Office of Research and later Senior Clinical Advisor and Director of the Quality Improvement Organization program in the Office of Clinical Standards and Quality. He led transformation of Medicare’s Quality Improvement Organization program from focusing on deficient providers to achieving national improvements in healthcare systems. From 2012 to 2016 he served as a Commissioner of the Maryland Health Services Cost Review Commission, which administers Maryland’s prospective all-payer hospital budgeting program. He has received the Ernest A. Codman Award and the Distinguished Service Medal of the U.S. Public Health Service, and six Secretary’s Distinguished Service Awards. He retired as Assistant Surgeon General in 2004.
Shivan Mehta is Associate Chief Innovation Officer at Penn Medicine and Assistant Professor of Medicine and Health Policy at the Perelman School of Medicine. He is also the Co-Director of Quality for the Gastroenterology division.
He leads a team of managers, designers, and engineers that develops, evaluates, and implements health care delivery innovations across Penn Medicine’s health system. Current projects focus on connecting with patients outside of traditional venues and accelerating the pace of experimentation across the system. Shivan also conducts research evaluating pragmatic trials of health care delivery that leverage behavioral science, care redesign, and information technology to improve population health outcomes in areas such as colorectal cancer screening, joint replacement surgery, hypertension management, and hepatitis C screening.
Shivan received his bachelor’s degree in economics from Yale University, his medical degree and master’s in health policy research from the University of Pennsylvania, and his MBA in health care management from the Wharton School.
My main areas of interest include cancer screening and prevention and treatment of chronic conditions, on improving medical decision-making. I have developed and tested interventions, including decision aids, to mitigate literacy-related health disparities and to improve the use of appropriate preventive services. I have published over 250 peer-reviewed journal articles and have over 15 years of mentoring students, fellows, and junior faculty in developing their own research agendas, obtaining funding, and publishing collaboratively in top-tiered scholarly journals.